2nd Next Generation RNA Therapeutics Summit
Bringing Next Generation RNA Therapies to Patients Faster
Newsletters and Deep Dive digital magazine
Bringing Next Generation RNA Therapies to Patients Faster
Italy’s antitrust authority has launched an investigation against eight pharma companies, including Novartis and Roche, over suspicion they may have colluded to delay the
Takeda has made a strong play for a stake in the Alzheimer’s disease market, paying $100 million upfront for an option on AC Immune’s amyloid-targeting immunotherapy.
The US FDA has recently proposed a new draft framework that enables pharma manufacturers to add software to a drug label if they can demonstrate that the software adds clinical benefit to t
Since late 2022, medications for Attention Deficit/Hyperactivity Disorder, or ADHD, have been in a shortage in the United States and the UK.
Digital health innovation (DHI) is a growing category of technologies that connect healthcare stakeholders and improve patient experiences and outcomes.
A pillar of commercial and reputational success, Medical Affairs is expected to play an important role as digital continues to reshape life sciences.
The PM Society Digital Awards have cemented their place as an unmissable highlight on the healthcare marketing calendar and 2024 will mark the 15th anniversary of the awards.
Your industry needs you for the PM Society Diversity, Equity, and Inclusion Interest Group benchmarking survey 2024.
Get in-depth news, opinions and features on pharma and healthcare sent straight to your inbox